TD Cowen analyst Bill Katz initiated coverage of CME Group with a Hold rating and $221 price target. CME is an attractive footprint, operating a dominant pure play derivatives platform that generates high margins and free cash flow, with potential for more balanced capital return algorithm in the wings, the analyst tells investors in a research note. The firm adds however that expect the stock will remain range-bound intermediate term as investors contend with three issues – the potential encroachment to monopolistic interest rate derivatives platform, decelerating interest rate average daily volue, and a rising index volatility.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- CME Group initiated with a Hold at TD Cowen
- Citi recommends overweight CME, underweight Cboe pair trade
- Buy/Sell: Wall Street’s top 10 stock calls this week
- CME Group to launch options on BCOM futures on September 23, pending review
- Citi opens ‘positive catalyst watch’ on CME into dividend announcement